Content validity was ensured through expert review and pilot testing.The questionnaire is provided as a supplementary file (Appendix 1) Statistical analysis Descriptive statistics were performed to summarize the demographic and clinical characteristics of the participants, including gender, age groups, BMI, and duration of GLP-1 use
A 2025 clinical study in women with PCOS and obesity (n=56) found tirzepatide led to significant weight reduction (mean 9.54%) and improvement in menstrual regularity: irregular cycles decreased from 85.7% before treatment to 32.1% after
Mitchell, Imperial College.
According to the Associated Press, trial participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams
Theres always been a preference in some parts of the population for oral formulations over injectables. Aitken said
Because Blue Cross Blue Shield operates as 34 independent companies, coverage for weight loss medication varies significantly by affiliate and plan type
